Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.
IPO Date: December 22, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $6.68B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.88 | 1.99%
Avg Daily Range (30 D): $0.63 | 1.58%
Avg Daily Range (90 D): $0.61 | 1.84%
Institutional Daily Volume
Avg Daily Volume: 1.15M
Avg Daily Volume (30 D): 1.57M
Avg Daily Volume (90 D): 1.39M
Trade Size
Avg Trade Size (Sh.): 85
Avg Trade Size (Sh.) (30 D): 62
Avg Trade Size (Sh.) (90 D): 62
Institutional Trades
Total Inst.Trades: 10,737
Avg Inst. Trade: $2.54M
Avg Inst. Trade (30 D): $3.21M
Avg Inst. Trade (90 D): $3.29M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $5.91M
Avg Closing Trade (30 D): $11.37M
Avg Closing Trade (90 D): $9.53M
Avg Closing Volume: 136.86K
   
News
Jul 21, 2025 @ 11:30 PM
Biogen to Highlight Scientific Progress Across Alz...
Source: Biogen Inc.
May 6, 2025 @ 5:00 PM
Angioedema Clinical Trial Pipeline Analysis Demons...
Source: Delveinsight
Mar 24, 2025 @ 12:00 PM
Praxis Precision Medicines to Present on Late-Stag...
Source: Praxis Precision Medicines, Inc.
Feb 20, 2025 @ 6:00 PM
BESREMi Achieves Strong Market Growth Amid Rising ...
Source: Delveinsight
Feb 19, 2025 @ 6:26 PM
Ionis Pharma Beats Expectations for Q4
Source: Jesterai
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-2.99 $-.93 $-.66
Diluted EPS $-2.99 $-.93 $-.66
Revenue $ 717.25M $ 131.61M $ 226.58M
Gross Profit $ 706.72M $ 130.15M $ 222.75M
Net Income / Loss $ -458.03M $ -146.94M $ -104.35M
Operating Income / Loss $ -472.43M $ -146.86M $ -110.82M
Cost of Revenue $ 10.53M $ 1.46M $ 3.83M
Net Cash Flow $ -84.77M $ 21.88M $ -92.04M
PE Ratio